National Comprehensive Cancer Network
- Educational Events & Resources
- NCCN Annual Conference: Clinical Practice Guidelines & Quality Cancer Care™
- NCCN Annual Congress: Hematologic Malignancies™
- NCCN Annual Forum: Innovative Diagnostics & Therapeutics in Cancer Care™
- Regional Guidelines in Oncology Symposia
- NCCN Academy for Excellence & Leadership in Oncology™
- NCCN Oncology Research Best Practices Conference™
- Interactive CME
- NCCN Oncology Case Management Program™
- NCCN International Programs
Clinical Recommendations
|
|
NCCN Clinical Practice Guidelines in Oncology Symposium: Colon, Rectal, & Anal Cancers – Therapy for Advanced DiseaseRecorded at a symposium held in Washington, DC, on November 5, 2007 Presenter Al B. Benson III, MD Faculty Disclosure Statement Dr. Benson has disclosed that he has financial interests, arrangements, or affiliations with the manufacturer of products and devices to be discussed in his presentation or who may financially support the educational activity. He has served as a consultant for Amgen Inc.; Bristol-Myers Squibb Company; Genentech, Inc.; ImClone Systems Incorporated; Pfizer Inc.; Roche Laboratories Inc.; and sanofi-aventis U.S. Dr. Benson has indicated that his presentation will not include discussion of investigational or unlabeled uses of a product. Program Overview NCCN, drawing on the expertise of faculty from its 21 Member Institutions, has developed and maintains clinical practice guidelines addressing colon cancer as part of its complete library of NCCN Clinical Practice Guidelines in Oncology™. This program will present the algorithm and focus on the integration of newer agents into the overall strategy for managing advanced disease. Educational Objectives Following this activity, participants should be able to:
Intended Audience This educational activity is designed to meet the needs of physicians, nurses, and other clinical professionals who manage patients with cancer. Activity Instructions Continuing education credit will be awarded to participants who listen to the presentation and complete the evaluation. Participants should review the learning objectives and faculty disclosure statements prior to listening to a presentation in its entirety. You must be connected to the Internet in order to review and complete the evaluation form. A statement of credit will be electronically generated once you complete the evaluation form. To receive credit, this activity must be completed no later than December 28, 2008. There is no fee for participating in this activity. Accreditation Information Physicians The National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. NCCN designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Nurses This activity is approved for 0.7 contact hours. National Comprehensive Cancer Network is an approved provider of continuing nursing education by the PA State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Approval as a provider refers to recognition of educational activities only and does not imply ANCC Commission on Accreditation or PA Nurses approval or endorsement of any product. Kristina M. Gregory, RN, MSN, OCN, is our nurse planner for this educational activity. Release date: December 28, 2007 Commercial Support Distribution supported by educational grants from Amgen Oncology, Bristol-Myers Squibb Company, Genentech BioOncology, ImClone Systems Incorporated, Pfizer Inc., Roche Laboratories Inc., and sanofi-aventis U.S.
|
Email
Print
Mark
|
|
|
||
|
|
|
|
|